1,659
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6–35 months in China

, , , , , , , , & show all
Pages 1691-1698 | Received 15 Nov 2019, Accepted 21 Jan 2020, Published online: 29 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Tia Aoun, Ray Borrow & Peter D. Arkwright. (2023) Immunogenicity and safety of seasonal influenza vaccines in children under 3 years of age. Expert Review of Vaccines 22:1, pages 226-242.
Read now
Xia Wei, Xue Tan, Qinghu Guan, Ruizhi Zhang, Shiguang Lei & Shaofeng Wei. (2023) Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis. Human Vaccines & Immunotherapeutics 19:2.
Read now
Xiaoqiang Liu, Juliana Park, Shengli Xia, Bin Liang, Shuangmin Yang, Yanxia Wang, Olga Syrkina, Nathalie Lavis, Shuzhen Liu, Chenyan Zhao, Jian Ding, Jieqiong Hu, Sandrine I. Samson & Iris A. de Bruijn. (2022) Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies. Human Vaccines & Immunotherapeutics 18:6.
Read now
Yan-Yang Tao, Jing-Xin Li, Yue-Mei Hu, Yuan-Sheng Hu, Gang Zeng & Feng-Cai Zhu. (2021) Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis. Expert Review of Vaccines 20:1, pages 1-11.
Read now

Articles from other publishers (6)

Rodrigo Luiz Carregaro, Alessandra N. C. P. Roscani, Augusto Cesar Sousa Raimundo, Larissa Ferreira, Tazio Vanni, Maria da Graça Salomão, Livia Fernandes Probst & Juliana Yukari K. Viscondi. (2023) Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews. BMC Infectious Diseases 23:1.
Crossref
Junhao Luo, Zhuohan Zhang, Song Zhao & Rongbao Gao. (2023) A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19. International Journal of Molecular Sciences 24:7, pages 6369.
Crossref
Praveen M. Varghese, Uday Kishore & Reena Rajkumari. (2022) Innate and adaptive immune responses against Influenza A Virus: Immune evasion and vaccination strategies. Immunobiology 227:6, pages 152279.
Crossref
Andrei A. Deviatkin, Ruslan A. Simonov, Kseniya A. Trutneva, Anna A. Maznina, Elena M. Khavina & Pavel Y. Volchkov. (2022) Universal Flu mRNA Vaccine: Promises, Prospects, and Problems. Vaccines 10:5, pages 709.
Crossref
Annette Fox, Louise Carolan, Vivian Leung, Hoang Vu Mai Phuong, Arseniy Khvorov, Maria Auladell, Yeu-Yang Tseng, Pham Quang Thai, Ian Barr, Kanta Subbarao, Le Thi Quynh Mai, H. Rogier van Doorn & Sheena G. Sullivan. (2022) Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses. Viruses 14:3, pages 470.
Crossref
Jidang Chen, Jiehuang Wang, Jipei Zhang & Hinh Ly. (2021) Advances in Development and Application of Influenza Vaccines. Frontiers in Immunology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.